Literature DB >> 11895158

Immunomodulation by perioperative administration of n-3 fatty acids.

G Weiss1, F Meyer, B Matthies, M Pross, W Koenig, H Lippert.   

Abstract

It has been increasingly reported that administration of n-3 fatty acids is beneficial in patients with inflammatory processes. This effect is most likely caused by different biological characteristics, including an immunomodulating effect of the products derived from n-3 fatty acids through eicosanoid metabolism. The aim of this study was to investigate the effect of perioperative administration of n-3 fatty acids on inflammatory and immune responses as well as on the postoperative course of patients with extended surgical interventions of the abdomen. In particular, the effect of n-3 fatty acids on interleukin-6 release and on granulocyte/monocyte function (HLA-DR expression) was studied. There was a downregulation of the inflammatory response, and, simultaneously, a smaller postoperative immune suppression in the n-3 fatty acid group. In addition, we observed shorter postoperative periods in the intensive care unit and on the regular medical wards as well as lower rates of severe infections. The results suggest that perioperative administration of n-3 fatty acids may have a favourable effect on outcome in patients with severe surgical interventions by lowering the magnitude of inflammatory response and by modulating the immune response.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11895158     DOI: 10.1079/bjn2001461

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  39 in total

1.  Immunonutrition.

Authors:  Philip C Calder
Journal:  BMJ       Date:  2003-07-19

Review 2.  Fish oil in critical illness: mechanisms and clinical applications.

Authors:  Renee D Stapleton; Julie M Martin; Konstantin Mayer
Journal:  Crit Care Clin       Date:  2010-07       Impact factor: 3.598

3.  Regulation of omega-3 fish oil emulsion on the SIRS during the initial stage of severe acute pancreatitis.

Authors:  Jiongxin Xiong; Shikai Zhu; Yu Zhou; Heshui Wu; Chunyou Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-02-18

4.  Attenuation of the systemic inflammatory response and infectious complications after gastrectomy with preoperative oral arginine and omega-3 fatty acids supplemented immunonutrition.

Authors:  Yoshiki Okamoto; Keiichi Okano; Kunihiko Izuishi; Hisashi Usuki; Hisao Wakabayashi; Yasuyuki Suzuki
Journal:  World J Surg       Date:  2009-09       Impact factor: 3.352

5.  Fish oil-supplemented parenteral nutrition in severe acute pancreatitis patients and effects on immune function and infectious risk: a randomized controlled trial.

Authors:  Xinying Wang; Weiqin Li; Feng Zhang; Liya Pan; Ning Li; Jieshou Li
Journal:  Inflammation       Date:  2009-10       Impact factor: 4.092

6.  Impact of supplementing preoperative intravenous omega 3 Fatty acids in fish oil on immunomodulation in elderly patients undergoing hip surgery.

Authors:  Ramachandran Gopinath; Sreekanth Yelliboina; Madhavi Singh; V B N Prasad
Journal:  Indian J Surg       Date:  2012-06-19       Impact factor: 0.656

Review 7.  Natural products and complementary therapies for chemotherapy-induced peripheral neuropathy: A systematic review.

Authors:  Cloé Brami; Ting Bao; Gary Deng
Journal:  Crit Rev Oncol Hematol       Date:  2015-11-23       Impact factor: 6.312

8.  Fish oil supplementation in the parenteral nutrition of critically ill medical patients: a randomised controlled trial.

Authors:  Sigrun Friesecke; Christian Lotze; Jenny Köhler; Annegret Heinrich; Stephan B Felix; Peter Abel
Journal:  Intensive Care Med       Date:  2008-03-21       Impact factor: 17.440

Review 9.  Lipid emulsions in parenteral nutrition of intensive care patients: current thinking and future directions.

Authors:  Philip C Calder; Gordon L Jensen; Berthold V Koletzko; Pierre Singer; Geert J A Wanten
Journal:  Intensive Care Med       Date:  2010-01-14       Impact factor: 17.440

10.  Effects of a fish oil containing lipid emulsion on plasma phospholipid fatty acids, inflammatory markers, and clinical outcomes in septic patients: a randomized, controlled clinical trial.

Authors:  Vera M Barbosa; Elizabeth A Miles; Conceição Calhau; Estevão Lafuente; Philip C Calder
Journal:  Crit Care       Date:  2010-01-19       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.